MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• MicroRNA (miR)-29a is linked to non-small cell lung cancer (NSCLC), but its precise role is unclear.
• LASP1, a protein promoting NSCLC proliferation and aggressiveness, has an unstudied regulatory mechanism in this cancer.
• The relationship between LASP1 and miR-29a in NSCLC has not been previously investigated.

Purpose of the Study:

• To elucidate the mechanism of miR-29a in NSCLC progression.
• To identify the regulatory relationship between miR-29a and LASP1 in NSCLC.
• To explore the potential of the miR-29a/LASP1 axis as a therapeutic target for NSCLC.

Main Methods:

• Bioinformatics analysis to predict gene targets.
• Luciferase reporter assays to validate gene regulation.
• In vitro cell culture experiments (proliferation, migration, invasion assays) and in vivo xenograft models in nude mice.

Main Results:

• miR-29a was significantly downregulated in NSCLC, correlating with malignant progression.
• LASP1 expression was markedly increased in NSCLC tissues and cell lines.
• LASP1 was identified as a direct target of miR-29a, with miR-29a negatively regulating LASP1 post-transcriptionally.
• miR-29a overexpression suppressed NSCLC cell proliferation, migration, and invasion, mimicking LASP1 knockdown.
• LASP1 overexpression counteracted the suppressive effects of miR-29a.
• Upregulation of miR-29a inhibited tumor growth in vivo and improved survival in a mouse model.

Conclusions:

• miR-29a exerts a suppressive role in NSCLC by targeting LASP1.
• The miR-29a/LASP1 axis is a critical regulator of NSCLC malignant phenotypes.
• The miR-29a/LASP1 pathway represents a promising therapeutic strategy for NSCLC.